Recent advances in the treatment of thromboembolic diseases: venous thromboembolism.
Venous thromboembolic diseases are the major concern of rising cost of healthcare and are commonest health problem across the globe. Both genetic and acquired risk factors are believed to be strongly linked with these diseases. Commonly encountered problems to the therapy include dose fixing and routine monitoring, yet some serious problems of bleeding also necessitate the immediate need to develop new agents. The review is primarily concerned with the new developments in the treatment of thromboembolic diseases. Therapeutic applications of anticoagulants, antiplatelets, and thrombolytics have been discussed in enough detail.
Agrawal
Y K
YK
Institute of Pharmacy, Nirma University of Science and Technology, Sarkhej-Gandhinagar Highway, Ahmedabad 382481, Gujarat, India. drykagrawal@yahoo.com
Vaidya
Hitesh
H
Bhatt
Hardik
H
Manna
Kuntal
K
Brahmkshatriya
Pathik
P
D000818:Animals; D030342:Genetic Diseases, Inborn / Q000188:drug therapy; D006401:Hematologic Agents / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D012307:Risk Factors; D013923:Thromboembolism / Q000188:drug therapy*; D019851:Thrombophilia / Q000188:drug therapy; D020246:Venous Thrombosis / Q000188:drug therapy*
D006401:Hematologic Agents